‘No Tobacco, No Sugar': 101-Year-Old Nutritionist Has 7 Rules For Long And Healthy Life
Last Updated:
Throughout his career, the California-based nutritionist has shared seven health tips, which he rigorously follows, to maintain his remarkable longevity.
Born in December 1923, Dr. John Scharffenberg is not just surviving but thriving at the age of 101. The California-based nutritionist has gained global recognition for living a happy and healthy life even after crossing the century mark. Scharffenberg recently shared his wisdom on achieving a long and prosperous life in an interview with Surrey Live. Despite his longevity, Scharffenberg rejected the idea that great genetics played a role in his long life. He revealed that his father passed away at 76 from a heart attack, his mother in her 60s, and he has outlived both of his brothers.
Currently living with his son in North Fork, located in the Sierra Nevada foothills, Scharffenberg has continued to travel the world, giving lectures as a professor at Loma Linda University's School of Public Health. Last year, he delivered talks in Madagascar and Europe, and he is scheduled to speak in Las Vegas in 2025. Throughout his career, Scharffenberg has shared seven health tips, which he rigorously follows, to maintain his remarkable longevity.
Exercise has been a key part of Scharffenberg's daily routine. The nutritionist credits his fitness and longevity to the physical work he underwent on a plot the man bought in California's San Joaquin Valley. Scharffenberg said he remained active through his pursuit to clear the land for a road and build 3,000 strawberry plants alongside 80 fruit trees.
'The time of life you get it is what's important — middle age, from 40 to 70," he was quoted by Surrey Live. 'That's when you need it, because that's the time when people usually relax, have more money, buy more food, sit around more, eat more […] and that's the wrong way to go. I did it all by myself, so I exercised a lot. I worked hard. Even though I'm a nutritionist, exercise is even more important than nutrition."
No Tobacco
Another golden rule Scharffenberg has followed sincerely is to completely avoid smoking and any form of tobacco consumption throughout his life. Mindful of the serious health challenges tobacco causes, including multiple organ damage and diseases such as cancer and type 2 diabetes, Dr Scharffenberg has made sure it has never entered his body.
Avoid Alcohol
Dr Scharffenberg challenged the notion that moderate drinking provides health benefits. While many claim that consuming a small glass of wine can be advantageous, the professor completely stands against it and has abstained from any alcohol consumption throughout his lifespan.
Scharffenberg recognised early that maintaining a light weight with minimal fat is the way to keep a range of medical issues, including heart problems and cancer, at bay. The nutritionist fasts intermittently, following a routine where he takes his breakfast and lunch but skips dinner. Scharffenberg doesn't eat anything until 6:30 am the next morning.
Reduce Meat Consumption
Breaking the myth that a diet must feature a host of non-vegetarian dishes for protein sufficiency and fulfilling, Dr Scharffenberg said he hasn't touched meat since his 20s. Completely cutting down on meat consumption early in life, the professor said he follows a plant-based regimen as per his Seventh-Day Adventist Church beliefs.
Eliminate Sugar
To maintain a light weight, one must cut down the calories consumed daily. Ensuring the same, Dr Scharffenberg has trimmed the sugar content from his diet to almost zero. The professor follows an effective recipe-tweaking method to achieve this goal, occasionally indulging in his wife's unique oat-based waffles with either berries or a mix of cashew cream and bananas and no sugar syrups. The doctor advises eating fruits and vital nutrients for safe sugar consumption.
Minimal Saturated Fats
Dr Scharffenberg promotes minimal usage of saturated fats, which he underlines as harmful for the body. The professor emphasised avoiding foods like butter, palm, coconut oils, cheese and red meat and gave a message to the readers, encouraging them to have an optimum diet. 'The optimum diet is the vegetarian diet. I pray that all of you will live the right lifestyle," he said.
Get Latest Updates on Movies, Breaking News On India, World, Live Cricket Scores, And Stock Market Updates. Also Download the News18 App to stay updated!
tags :
nutritionist tobacco viral news
Location :
Delhi, India, India
First Published:
April 25, 2025, 12:21 IST
News viral 'No Tobacco, No Sugar': 101-Year-Old Nutritionist Has 7 Rules For Long And Healthy Life
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
4 hours ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
Time of India
4 hours ago
- Time of India
KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin America. Both parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June end. As with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) valuation. ART Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and India. Live Events With clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Capital. ART Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and Faridabad. Led by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine years. According to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million. "For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well." IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals. A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to queries. Moelis is the advisor in the transaction. India is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in Europe. Infertility affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and pollution. According to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%. India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall Clinic. Nova IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and TPG. Similarly, homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
Time of India
5 hours ago
- Time of India
DCA seizes stocks of banned medicated soap
1 2 3 H yderabad: The Drugs Control Administration (DCA) officials in Karimnagar conducted a raid and seized stocks of a banned medicated soap that was being sold illegally on Sunday. Acting on a tip-off, they raided PLN Pharma Distributors in Karimnagar and found Dr Ethix's MediSkin Medicated Soap, which contains the prohibited combination of permethrin, cetrimide and menthol. The soap had been illegally manufactured by Maxwell Pharma in Solan, Himachal Pradesh, for the Chennai-based company Dr Ethix Products and Services. According to officials, this specific drug combination was banned by the central government in 2018 due to a lack of therapeutic justification and public health concerns. The prohibition covers the manufacture, distribution and sale of the soap for human use across the country. Further investigation is being carried out on the drug samples collected.
